Skip to main content

Month: June 2024

The net asset value of EfTEN Real Estate Fund AS shares as of 31.05.2024

EfTEN Real Estate Fund AS consolidated rental income was 2,589 thousand euros in May, an increase of 44 thousand euros compared to April. The growth in rental income was driven by turnover rents from shopping centers and from the seasonal revenue. The Fund’s consolidated EBITDA for May was 2,253 thousand euros, which is 78 thousand euros higher than the previous month. The May EBITDA includes a one-time income of 29 thousand euros from establishing an easement on a logistics center property in Tallinn. The consolidated rental income for the first five months of this year totaled 12,771 thousand euros, representing a 1% increase compared to the same period last year. The Fund’s EBITDA for the five months this year is 10,889 thousand euros, also a 1% increase compared to the same period last year. The vacancy rate of the Fund’s...

Continue reading

Market Update – June 11, 2024

Press Release Market update Atos’ Board of Directors has decided to proceed with the financial restructuring proposal submitted by the Onepoint consortium consisting of Onepoint, Butler Industries and Econocom, and a group of some of the Company’s financial creditors. Atos’ Board of Directors has concluded, under the aegis of the Conciliator, that the proposal received from the Onepoint consortium:Aligns with the corporate interest of the Company, particularly its employees and clients; Is generally consistent with the key financial parameters outlined in April by the Company, notably providing adequate financial liquidity to fund the business and ensuring a stronger capital structure; Has the support of a large number of Atos’ financial creditors and thus gives greater confidence in reaching a definitive financial restructuring agreement.Atos...

Continue reading

Ultimovacs provides update from Phase I study in malignant melanoma: Continued strong overall survival in patients treated with UV1 cancer vaccine and pembrolizumab

All patients in the trial who were alive at 3 years remain alive at 4 years (69.5%) with a minimum follow-up period of 4 years (median 53.0 months) The expected next key milestone for UV1 is the readout of the FOCUS trial during Q3 2024, in which the treatment combination is the same as in the UV1-103 trialOslo, June 11, 2024: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing immunotherapeutic cancer vaccines, today announced encouraging overall survival (OS) data from both cohorts in the UV1-103 Phase I clinical trial in malignant melanoma. The UV1-103 study evaluates Ultimovacs’ universal cancer vaccine, UV1, in combination with the anti-PD-1 checkpoint inhibitor pembrolizumab, as first-line treatment in patients with advanced non-resectable or metastatic malignant melanoma. The study enrolled...

Continue reading

Dassault Systèmes: Valeo partners with Dassault Systèmes to accelerate the digitalization of its R&D

PRESS RELEASEParis, June 11, 2024 Valeo partners with Dassault Systèmes to accelerate the digitalization of its R&DValeo will deploy Dassault Systèmes’ 3DEXPERIENCE platform to optimize the development of new technologies for safer and more sustainable mobility More than 15,000 Valeo users across R&D, purchasing, manufacturing and other areas will be connected in a virtual ecosystem featuring generative design and data science capabilities The deployment will help Valeo develop the technologies needed to make the car more electrified, autonomous and software driven. It will also support the optimization of the company’s research and development expenses.Valeo, a world leader in mobility technologies, and Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced their partnership. Valeo will rely on Dassault...

Continue reading

European Residential Real Estate Investment Trust Announces Results of 2024 Annual and Special Meeting

TORONTO, June 10, 2024 (GLOBE NEWSWIRE) — European Residential Real Estate Investment Trust (TSX: ERE.UN) (“ERES”) announced today that, at its Annual and Special Meeting of Unitholders held today, each of the items of business referred to in its management information circular dated April 15, 2024 (the “Circular”) were passed by a vote held by ballot. A total of 187,117,452 units and special voting units of ERES (collectively, “Units”) representing 80.033% of ERES’s issued and outstanding Units were voted in connection with the meeting. The voting results for each item of business are as follows: Election of Trustees:Nominee VotesFor % VotesFor VotesWithheld % VotesWithheldHarold Burke 183,286,181 97.988% 3,762,944 2.012%Gina Parvaneh Cody 185,844,759 99.356% 1,204,366 0.644%Ira Gluskin 181,707,515 97.144% 5,341,610 2.856%Mark...

Continue reading

CAPREIT Announces Results of 2024 Annual General Meeting

TORONTO, June 10, 2024 (GLOBE NEWSWIRE) — Canadian Apartment Properties Real Estate Investment Trust (TSX:CAR.UN) (“CAPREIT”) announced today that, at its Annual Meeting of Unitholders held today (the “Meeting”), each of the items of business referred to in its management information circular dated April 11, 2024 (the “Circular”) were passed by a vote held by ballot. A total of 113,635,302 units and special voting units of CAPREIT (collectively, “Units”), in the aggregate, representing 67.34% of CAPREIT’s issued and outstanding Units were voted in connection with the Meeting. The voting results for each item of business are as follows: Election of Trustees: All nominees proposed in the Circular were elected as trustees.Nominee Votes For % Votes For Votes Withheld % Votes WithheldLori-Ann Beausoleil 113,088,338 99.88% 134,023 0.12%Harold...

Continue reading

CoreCivic Receives Termination Notice From U.S. Immigration and Customs Enforcement At South Texas Family Residential Center

BRENTWOOD, Tenn., June 10, 2024 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (“CoreCivic”) received notification today from U.S. Immigration and Customs Enforcement (“ICE”) that the agency intends to terminate an inter-governmental service agreement (“IGSA”) between CoreCivic and ICE for services at the South Texas Family Residential Center in Dilley, TX (the “Facility”) effective in 60 days, or on or about August 9, 2024. For the year ended December 31, 2023, and for the quarter ended March 31, 2024, total revenues at the Facility were $156.6 million and $39.3 million, respectively. Given that the notice of termination was received today and based on cost uncertainties associated with the closure, CoreCivic is suspending its financial guidance for 2024. However, we estimate the annualized financial impact...

Continue reading

Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified stock option awards to purchase an aggregate of 158,000 shares of its common stock to nine new non-executive employees under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4). The 2021 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Crinetics, or following a bona fide period of non-employment, as an inducement material to such individuals’...

Continue reading

Centurion Acquisition Corp. Announces Pricing of $250 Million Initial Public Offering

NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) — Centurion Acquisition Corp. (the “Company”) today announced the pricing of its initial public offering of 25,000,000 units at a price of $10.00 per unit. The units will be listed on the Nasdaq Global Market (“Nasdaq”) and will trade under the ticker symbol “ALFUU” beginning on June 11, 2024. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants will be exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “ALF” and “ALFUW,” respectively. The offering is expected to close on June 12, 2024. Centurion Acquisition...

Continue reading

End of the BAPE Public Information Period 

A Positive Exercise for Falco MONTRÉAL, June 10, 2024 (GLOBE NEWSWIRE) — Falco Resources Ltd. (TSX.V: FPC) (“Falco” or the “Corporation”) would like to thank all those who participated and enriched the discussions during the public information period of the Bureau d’audiences publiques sur l’environnement (BAPE) and reiterates its commitment to working closely with the community, environmental groups, and authorities for the success of Falco’s Horne 5 Project (“Falco’s Horne 5 Project” or the “Project”). This information period, which was held from April 24 to June 10, 2024, allowed citizens, groups, the municipality and organizations to learn about the various environmental, economic and social aspects of the Project. During this period, it was also possible to make requests for public consultation or mediation to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.